Aptus Capital Advisors’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $15.5M | Buy |
42,764
+1,298
| +3% | +$444K | 0.11% | 159 |
|
|
2026
Q1 | $14.6M | Sell |
41,466
-3,205
| -7% | -$1.14M | 0.11% | 156 |
|
|
2025
Q4 | $14.6M | Buy |
44,671
+284
| +0.6% | +$90.1K | 0.1% | 165 |
|
|
2025
Q3 | $12.5M | Sell |
44,387
-1,546
| -3% | -$448K | 0.09% | 179 |
|
|
2025
Q2 | $12.8M | Sell |
45,933
-1,667
| -4% | -$472K | 0.1% | 164 |
|
|
2025
Q1 | $14.8M | Buy |
47,600
+3,987
| +9% | +$1.18M | 0.15% | 135 |
|
|
2024
Q4 | $11.4M | Buy |
43,613
+16,380
| +60% | +$4.86M | 0.12% | 151 |
|
|
2024
Q3 | $8.77M | Buy |
27,233
+5,515
| +25% | +$1.8M | 0.13% | 148 |
|
|
2024
Q2 | $6.79M | Buy |
21,718
+4,169
| +24% | +$1.22M | 0.12% | 148 |
|
|
2024
Q1 | $4.99M | Sell |
17,549
-1,979
| -10% | -$579K | 0.09% | 181 |
|
|
2023
Q4 | $5.62M | Buy |
19,528
+2
| +0% | +$545 | 0.15% | 120 |
|
|
2023
Q3 | $5.25M | Sell |
19,526
-243
| -1% | -$60.6K | 0.14% | 126 |
|
|
2023
Q2 | $4.39M | Buy |
19,769
+17,683
| +848% | +$4.1M | 0.11% | 153 |
|
|
2023
Q1 | $504K | Sell |
2,086
-10,391
| -83% | -$2.55M | 0.01% | 324 |
|
|
2022
Q4 | $3.28M | Buy |
12,477
+10,325
| +480% | +$2.77M | 0.1% | 168 |
|
|
2022
Q3 | $485K | Sell |
2,152
-29
| -1% | -$7.03K | 0.01% | 330 |
|
|
2022
Q2 | $531K | Buy |
2,181
+190
| +10% | +$46.6K | 0.01% | 276 |
|
|
2022
Q1 | $481K | Buy |
1,991
+994
| +100% | +$228K | 0.01% | 310 |
|
|
2021
Q4 | $224K | Sell |
997
-9,163
| -90% | -$1.93M | 0.01% | 351 |
|
|
2021
Q3 | $2.16M | Sell |
10,160
-6,887
| -40% | -$1.59M | 0.06% | 156 |
|
|
2021
Q2 | $4.16M | Buy |
17,047
+1,399
| +9% | +$344K | 0.12% | 89 |
|
|
2021
Q1 | $3.89M | Buy |
15,648
+25
| +0.2% | +$5.96K | 0.14% | 82 |
|
|
2020
Q4 | $3.59M | Buy |
15,623
+2,447
| +19% | +$564K | 0.16% | 84 |
|
|
2020
Q3 | $3.35M | Buy |
13,176
+438
| +3% | +$109K | 0.18% | 77 |
|
|
2020
Q2 | $3M | Buy |
12,738
+1,052
| +9% | +$240K | 0.19% | 75 |
|
|
2020
Q1 | $2.37M | Buy |
11,686
+1,426
| +14% | +$311K | 0.2% | 79 |
|
|
2019
Q4 | $2.47M | Buy |
10,260
+2,367
| +30% | +$522K | 0.18% | 121 |
|
|
2019
Q3 | $1.53M | Sell |
7,893
-544
| -6% | -$104K | 0.09% | 140 |
|
|
2019
Q2 | $1.55M | Buy |
8,437
+86
| +1% | +$15.4K | 0.22% | 82 |
|
|
2019
Q1 | $1.59M | Buy |
8,351
+79
| +1% | +$15.1K | 0.27% | 89 |
|
|
2018
Q4 | $1.61M | Buy |
+8,272
| New | +$1.61M | 0.42% | 24 |
|
Other funds holding AMGN
Aptus Capital Advisors's AMGN Position: Q2 2026 in Review
Aptus Capital Advisors increased its Amgen (AMGN) stake by 3.1% in Q2 2026, buying an estimated $444K and bringing the position to 42,764 shares worth $15.5M. The position accounts for 0.11% of the portfolio, ranked #159.
Aptus Capital Advisors first reported a position in AMGN in Q4 2018 and has held it in 31 quarters since. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Aptus Capital Advisors held 42,764 shares of Amgen worth $15.5M as of Q2 2026.
- Aptus Capital Advisors bought 1,298 Amgen shares in Q2 2026, an estimated $444K.
- Amgen made up 0.11% of Aptus Capital Advisors's portfolio in Q2 2026, its #159 holding.
- Aptus Capital Advisors first reported a position in Amgen in Q4 2018 and has held it in 31 quarters since.
- 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Aptus Capital Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.